Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 286-484-6 | CAS number: 85251-71-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
In vitro and in vivo studies on dermal and ocular irritation have been conducted on C14, C16, C18 fatty acid lithium salts, and in vitro/in vivo eye irritation studies with calcium myristate. No classifiable irritant responses were observed relevant to calcium salts of C14-22 fatty acids.
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The substances in the category are considered to be similar on the basis that they have common structures of a calcium ion varying only by the length of the fatty acid chain and the presence of unsaturated and/or hydroxyl functional groups. As a result it is expected that the substances will have similar, predictable properties. REACH Annex V, Entry 9, groups fatty acids and their potassium, sodium, calcium and magnesium salts, including C6 to C24, predominantly even-numbered, unbranched, saturated or unsaturated aliphatic monocarboxylic acids. Provided that they are obtained from natural sources and are not chemically modified, the substances included in REACH Annex V, Entry 9 are exempt from registration, unless they are classified as dangerous (except for flammability, skin irritation or eye irritation) or they meet the criteria for PBT/vPvB substances. The metal fatty acid substances in the category are therefore not expected to be hazardous. Due to the close structural similarity and the narrow range of carbon chain numbers covered in this category, the irritation properties are expected to be predictable across the category.
Since REACH Annex V groups together calcium, potassium, sodium and magnesium salts of C6 to C24 fatty acids as being potentially exempt from registration, these metal cations are therefore not considered to contribute to any health hazard. On this basis, relevant published or proprietary data on any potassium, sodium or magnesium salt within the fatty acid category range of C14 to C22 can be used to read across to the calcium salts of C14-C22 fatty acid category.
Lithium salts of fatty acids are not included in REACH Annex V as being potentially exempt from registration. For these salts it is expected that the lithium cation would be the species with the potentially higher toxicity profile when compared to calcium, potassium, sodium, and magnesium cations. However, the substance fatty acids C18 (unsaturated) lithium salts contains a fatty acid anion that falls within the C14-C22 category. Experimental data for the mammalian toxicity Annex VIII endpoints have been generated on this substance and the results obtained are relevant to read across to the calcium salts of C14-C22 fatty acids either in a weight of evidence approach or as key studies due to the structural similarity and its position within the category fatty acid range. Additionally, ocular irritation studies have been conducted on lithium palmitate.
Published reviews consider that the irritant/corrosivity properties of fatty acids are chain length dependent, where the lower carbon chain lengths, < C9 are corrosive, C10 – C12 are irritant, and chain lengths from C14 are not irritating (HERA 2002), referencing Briggs et al, 1976 and CIR, 1987). Key in vitro and in vivo ocular irritation studies have been conducted on the category member with the shortest chain length, calcium myristate, since that would be considered the ‘worst case’ substance for irritation based on the relationship to chain length. The in vitro study (Rabbit Eye Enucleation Test - REET) showed no evidence of severe irritation/corrosivity, and the in vivo OECD Guideline 405 study demonstrated no classifiable eye irritation. Since the fatty acid salts with longer chain lengths are considered to have proportionately lower irritation potential, this negative result can be read across to the other category members. This is also supported by read across data from ocular irritation studies on relevant lithium fatty acid salts with longer carbon chain lengths. Negative in vitro and in vivo (OECD Guideline 405) studies were conducted on lithium palmitate (C16) and fatty acids, C18 (unsaturated), lithium salts. Since the lithium cation might be expected to demonstrate higher irritation potential than the calcium cations, reading across the negative results to the latter category is validated. Further supporting evidence is shown by a negative published eye irritation study on magnesium stearate, taken from a peer-reviewed article.
The dermal corrosion and irritant properties of magnesium stearate to the intact and abraded skin of rabbits were evaluated in a published supporting study. A primary irritation index of 0.0 was obtained after four hours exposure under occlusive dressing. Although no information on the test methods is available in the publications, it is a peer-reviewed article and considered reliable and relevant for assessment of this endpoint. A supporting study in rabbits for skin irritation using a grease formulated with calcium 12-hydroxystearate has been conducted and the formulation was non-irritant.
Key in vitro skin irritation studies on lithium myristate (C14) and fatty acids C18 (unsaturated) lithium salts gave negative results. The negative results from the studies with the lithium fatty acid salts are suitable for reading across to the calcium fatty acid salts for the reasons mentioned above. Since the irritation properties of fatty acids and their salts are inversely proportional to carbon chain length, the negative results are applicable for the whole category from C14 to C22.
Overall, the calcium fatty acid salts of C14 to C22 fatty acids are not considered to be skin or ocular irritants.
References
Briggs GB, Doyle RL, Young JA (1976) Safety studies on a series of fatty acids. American Industrial Hygiene Association Journal, vol. 37, pp. 251-252
CIR (Cosmetics Ingredients Review) (1987) Final report on the safety assessment of oleic acid, lauric acid, palmitic acid, myristic acid and stearic acid. Journal of American Toxicologists, vol. 6, issue 3, pp. 321-401
HERA (Human Health and Environmental Risk Assessment on ingredients of European household cleaning products) (2002) Fatty Acid Salts (Soap) Environmental and Human Health Risk AssessmentJustification for selection of skin irritation / corrosion endpoint:
This substance is a representative fatty acid salt that can be read across to the calcium salts of C14-C22 fatty acids category
Justification for classification or non-classification
Not classified under the EU CLP Regulation. All studies were negative.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
